SilicoLife will be present in the next “BlueYard Conversation on the future of biology: engineering life with software“. This session organized by the Berlin based VC BlueYard Capital will gather founders, CEOs and key executives from SynBio startups, academics, science journalists and other people from the wider ecosystem to discuss the synthetic biology technology stack and applications, the emerging SynBio ecosystem, and public and private engagement in the SynBio movement.

Simão Soares, SilicoLife CEO, will speak in the panel “The Computation Challenge Within Synthetic Biology”.